Skip to Content

Tenet Healthcare Corp

View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation

Tenet Earnings: Robust Utilization Trends and Expanded Services Support Our Valuation Increase

No-moat Tenet ended the year with strong fourth-quarter results above our expectations. We are raising our fair value estimate to $104 per share from $95 mainly due to higher margin projections as the company continues to expand its high-acuity service lines and improve its operating efficiency. We applaud Tenet’s efforts to enhance its credit profile through hospital portfolio optimization and debt retirement. In our view, despite the 60% stock price rally since last November, Tenet’s shares remain moderately undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of THC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center